Details for New Drug Application (NDA): 080248
✉ Email this page to a colleague
NDA 080248 describes ALBALON, which is a drug marketed by Allergan and is included in one NDA. Additional details are available on the ALBALON profile page.
The generic ingredient in ALBALON is naphazoline hydrochloride. There are eight drug master file entries for this compound. Additional details are available on the naphazoline hydrochloride profile page.
The generic ingredient in ALBALON is naphazoline hydrochloride. There are eight drug master file entries for this compound. Additional details are available on the naphazoline hydrochloride profile page.
Summary for 080248
| Tradename: | ALBALON |
| Applicant: | Allergan |
| Ingredient: | naphazoline hydrochloride |
| Patents: | 0 |
Medical Subject Heading (MeSH) Categories for 080248
Profile for product number 001
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | SOLUTION/DROPS;OPHTHALMIC | Strength | 0.1% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | ||||
| Approval Date: | Approved Prior to Jan 1, 1982 | TE: | RLD: | No | |||||
Complete Access Available with Subscription
